Pfizer Recalls Oxbryta: Sickle Cell Patients File Lawsuits
See Details
Proof Required?
Pfizer has recalled Oxbryta (voxelotor), a medication used to treat sickle cell disease, leading to lawsuits from affected patients. Oxbryta was voluntarily withdrawn from the market due to safety concerns, leaving many sickle cell patients who relied on this treatment seeking answers and potential compensation.
If you or a loved one took Oxbryta for sickle cell disease, you may be entitled to compensation through ongoing legal action. The recall has affected patients who depended on this medication for managing their condition, and lawsuits are being filed to hold Pfizer accountable for any harm caused.
Who Is Eligible?
You may be eligible to file a claim if you:
- Patients who were prescribed and took Oxbryta (voxelotor) for sickle cell disease
- Individuals who experienced adverse effects or complications while taking Oxbryta
- Patients whose treatment was disrupted due to the recall
- Family members of patients who may have been harmed by Oxbryta
How Much Can You Get?
Compensation details are still being determined as the legal proceedings develop. Potential damages may include reimbursement for medical expenses, costs related to switching medications, pain and suffering, and other losses related to taking Oxbryta or being affected by its recall.
How to File Your Claim
Filing your claim is quick and easy:
- Gather your medical records showing Oxbryta prescription and use
- Document any adverse effects or complications you experienced
- Collect receipts for medical expenses related to Oxbryta treatment
- Consult with legal professionals handling Oxbryta cases
- Download Class Action Buddy to stay updated on filing opportunities and get help with your claim
💡 Easier way: File with Class Action Buddy
Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.
Download for iPhone
Download for Android
Frequently Asked Questions
Why was Oxbryta recalled by Pfizer?
Pfizer voluntarily recalled Oxbryta due to safety concerns, though specific details about the safety issues are still being investigated through ongoing legal proceedings.
Who can file an Oxbryta lawsuit?
Patients who took Oxbryta for sickle cell disease and experienced adverse effects, as well as those whose treatment was disrupted by the recall, may be eligible to file a lawsuit or join class action litigation.
What compensation might be available for Oxbryta patients?
While specific amounts are pending, compensation may include medical expenses, costs of switching treatments, pain and suffering, and other damages related to Oxbryta use or the recall's impact on patient care.
Get Notified About New Settlements
We find new class action settlements every week. Get alerts so you never miss free money.
No spam. Unsubscribe anytime. We respect your privacy.